Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function

Human Molecular Genetics

Volumn 21, Issue 8, 2012, Pages 1861-1876

  Ciron, C ^a   Lengacher, S ^a   Dusonchet, J ^a   Aebischer, P ^a   Schneider, B L ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; MITOCHONDRIAL GENE; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM;

ADENOSINE TRIPHOSPHATE; ALPHA-SYNUCLEIN; ANIMALS; CELL RESPIRATION; CELL SURVIVAL; CELLS, CULTURED; CORPUS STRIATUM; DEPENDOVIRUS; DOPAMINE; DOPAMINERGIC NEURONS; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; NERVE DEGENERATION; NEURONS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TRANS-ACTIVATORS;

ADENO-ASSOCIATED VIRUS; RATTUS;

EID: 84859242538     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr618     Document Type: Article

References (58)

1. Schon, E.A. and Manfredi, G. (2003) Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest., 111, 303-312.
2. Beal, M.F. (2005) Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol., 58, 495-505.
3. Jones, D.C. and Miller, G.W. (2008) The effects of environmental neurotoxicants on the dopaminergic system: a possible role in drug addiction. Biochem. Pharmacol., 76, 569-581.
4. Vila, M., Ramonet, D. and Perier, C. (2008) Mitochondrial alterations in Parkinson's disease: new clues. J. Neurochem., 107, 317-328.
5. Clark, I.E., Dodson, M.W., Jiang, C., Cao, J.H., Huh, J.R., Seol, J.H., Yoo, S.J., Hay, B.A. and Guo, M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature, 441, 1162-1166.
6. Deng, H., Dodson, M.W., Huang, H. and Guo, M. (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl Acad. Sci. USA, 105, 14503-14508.
7. Koh, H. and Chung, J. (2010) PINK1 and Parkin to control mitochondria remodeling. Anat. Cell Biol., 43, 179-184.
8. Devi, L., Raghavendran, V., Prabhu, B.M., Avadhani, N.G. and Anandatheerthavarada, H.K. (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem., 283, 9089-9100.
9. Martin, L.J., Pan, Y., Price, A.C., Sterling, W., Copeland, N.G., Jenkins, N.A., Price, D.L. and Lee, M.K. (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci., 26, 41-50.
10. Parihar, M.S., Parihar, A., Fujita, M., Hashimoto, M. and Ghafourifar, P. (2008) Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol. Life Sci., 65, 1272-1284.
11. Lashuel, H.A., Petre, B.M., Wall, J., Simon, M., Nowak, R.J., Walz, T. and Lansbury, P.T. Jr (2002) Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol. Biol., 322, 1089-1102.
12. Puigserver, P. (2005) Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int. J. Obes. (Lond.), 29 (Suppl. 1), S5-S9.
13. Finck, B.N. and Kelly, D.P. (2006) PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest., 116, 615-622.
14. Schreiber, S.N., Emter, R., Hock, M.B., Knutti, D., Cardenas, J., Podvinec, M., Oakeley, E.J. and Kralli, A. (2004) The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc. Natl Acad. Sci. USA, 101, 6472-6477.
15. Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R.C. et al. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 98, 115-124.
16. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J.M., Rhee, J., Jager, S., Handschin, C., Zheng, K., Lin, J., Yang, W. et al. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127, 397-408.
17. Weydt, P., Pineda, V.V., Torrence, A.E., Libby, R.T., Satterfield, T.F., Lazarowski, E.R., Gilbert, M.L., Morton, G.J., Bammler, T.K., Strand, A.D. et al. (2006) Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab., 4, 349-362.
18. Cui, L., Jeong, H., Borovecki, F., Parkhurst, C.N., Tanese, N. and Krainc, D. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127, 59-69.
19. Qin, W., Haroutunian, V., Katsel, P., Cardozo, C.P., Ho, L., Buxbaum, J.D. and Pasinetti, G.M. (2009) PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch. Neurol., 66, 352-361.
20. Zheng, B., Liao, Z., Locascio, J.J., Lesniak, K.A., Roderick, S.S., Watt, M.L., Eklund, A.C., Zhang-James, Y., Kim, P.D., Hauser, M.A. et al. (2010) PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci. Transl. Med., 2, 52ra73.
21. Pacelli, C., De Rasmo, D., Signorile, A., Grattagliano, I., di Tullio, G., D'Orazio, A., Nico, B., Comi, G.P., Ronchi, D., Ferranini, E. et al. (2011) Mitochondrial defect and PGC-1alpha dysfunction in parkin-associated familial Parkinson's disease. Biochim. Biophys. Acta., 1812, 1041-1053.
22. Weydt, P., Soyal, S.M., Gellera, C., Didonato, S., Weidinger, C., Oberkofler, H., Landwehrmeyer, G.B. and Patsch, W. (2009) The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. Mol. Neurodegener., 4, 3.
23. Zhao, W., Varghese, M., Yemul, S., Pan, Y., Cheng, A., Marano, P., Hassan, S., Vempati, P., Chen, F., Qian, X. et al. (2011) Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol. Neurodegener., 6, 51.
24. Liang, H., Ward, W.F., Jang, Y.C., Bhattacharya, A., Bokov, A.F., Li, Y., Jernigan, A., Richardson, A. and Van Remmen, H. (2011) PGC-1alpha protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model. Muscle Nerve, 44, 947-956.
25. Shimizu, S., Eguchi, Y., Kamiike, W., Funahashi, Y., Mignon, A., Lacronique, V., Matsuda, H. and Tsujimoto, Y. (1998) Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl Acad. Sci. USA, 95, 1455-1459.
26. Cowell, R.M., Blake, K.R. and Russell, J.W. (2007) Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain. J. Comp. Neurol., 502, 1-18.
27. Lucas, E.K., Markwardt, S.J., Gupta, S., Meador-Woodruff, J.H., Lin, J.D., Overstreet-Wadiche, L. and Cowell, R.M. (2010) Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha. J. Neurosci., 30, 7227-7235.
28. Azeredo da Silveira, S., Schneider, B.L., Cifuentes-Diaz, C., Sage, D., Abbas-Terki, T., Iwatsubo, T., Unser, M. and Aebischer, P. (2009) Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease. Hum. Mol. Genet., 18, 872-887.
29. Andreyev, A.Y., Kushnareva, Y.E. and Starkov, A.A. (2005) Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc.), 70, 200-214.
30. Bauer, M.K., Schubert, A., Rocks, O. and Grimm, S. (1999) Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J. Cell Biol., 147, 1493-1502.
31. Halestrap, A.P. (2004) Mitochondrial permeability: dual role for the ADP/ ATP translocator? Nature, 430, 1 following 983.
32. Echtay, K.S., Roussel, D., St-Pierre, J., Jekabsons, M.B., Cadenas, S., Stuart, J.A., Harper, J.A., Roebuck, S.J., Morrison, A., Pickering, S. et al. (2002) Superoxide activates mitochondrial uncoupling proteins. Nature, 415, 96-99.
33. Talbot, D.A., Lambert, A.J. and Brand, M.D. (2004) Production of endogenous matrix superoxide from mitochondrial complex I leads to activation of uncoupling protein 3. FEBS Lett., 556, 111-115.
34. Zhang, J. and Ney, P.A. (2009) Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ., 16, 939-946.
35. Li, Y., Huang, T.T., Carlson, E.J., Melov, S., Ursell, P.C., Olson, J.L., Noble, L.J., Yoshimura, M.P., Berger, C., Chan, P.H. et al. (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet., 11, 376-381.
36. Wagner, O.I., Lifshitz, J., Janmey, P.A., Linden, M., McIntosh, T.K. and Leterrier, J.F. (2003) Mechanisms of mitochondria-neurofilament interactions. J. Neurosci., 23, 9046-9058.
37. Miller, K.E. and Sheetz, M.P. (2004) Axonal mitochondrial transport and potential are correlated. J. Cell Sci., 117, 2791-2804.
38. Willy, P.J., Murray, I.R., Qian, J., Busch, B.B., Stevens, W.C. Jr, Martin, R., Mohan, R., Zhou, S., Ordentlich, P., Wei, P. et al. (2004) Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc. Natl Acad. Sci. USA, 101, 8912-8917.
39. Spina, M.B. and Cohen, G. (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc. Natl Acad. Sci. USA, 86, 1398-1400.
40. Maetzler, W., Nitsch, C., Bendfeldt, K., Racay, P., Vollenweider, F. and Schwaller, B. (2004) Ectopic parvalbumin expression in mouse forebrain neurons increases excitotoxic injury provoked by ibotenic acid injection into the striatum. Exp. Neurol., 186, 78-88.
41. Li, Z., Okamoto, K., Hayashi, Y. and Sheng, M. (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell, 119, 873-887.
42. Kang, J.S., Tian, J.H., Pan, P.Y., Zald, P., Li, C., Deng, C. and Sheng, Z.H. (2008) Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell, 132, 137-148.
43. Chang, D.T., Honick, A.S. and Reynolds, I.J. (2006) Mitochondrial trafficking to synapses in cultured primary cortical neurons. J. Neurosci., 26, 7035-7045.
44. Davey, G.P., Peuchen, S. and Clark, J.B. (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J. Biol. Chem., 21, 12753-12757.
45. Sulzer, D. (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci., 30, 244-250.
46. Lehman, J.J., Barger, P.M., Kovacs, A., Saffitz, J.E., Medeiros, D.M. and Kelly, D.P. (2000) Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest., 106, 847-856.
47. Russell, L.K., Mansfield, C.M., Lehman, J.J., Kovacs, A., Courtois, M., Saffitz, J.E., Medeiros, D.M., Valencik, M.L., McDonald, J.A. and Kelly, D.P. (2004) Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ. Res., 94, 525-533.
48. Miura, S., Tomitsuka, E., Kamei, Y., Yamazaki, T., Kai, Y., Tamura, M., Kita, K., Nishino, I. and Ezaki, O. (2006) Overexpression of peroxisome proliferator-activated receptor gamma co-activator-1alpha leads to muscle atrophy with depletion of ATP. Am. J. Pathol., 169, 1129-1139.
49. Bonen, A. (2009) PGC-1alpha-induced improvements in skeletal muscle metabolism and insulin sensitivity. Appl. Physiol. Nutr. Metab., 34, 307-314.
50. Shin, J.H., Ko, H.S., Kang, H., Lee, Y., Lee, Y.I., Pletinkova, O., Troconso, J.C., Dawson, V.L. and Dawson, T.M. (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell, 144, 689-702.
51. Breidert, T., Callebert, J., Heneka, M.T., Landreth, G., Launay, J.M. and Hirsch, E.C. (2002) Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease. J. Neurochem., 82, 615-624.
52. Swanson, C.R., Joers, V., Bondarenko, V., Brunner, K., Simmons, H.A., Ziegler, T.E., Kemnitz, J.W., Johnson, J.A. and Emborg, M.E. (2011) The PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J. Neuroinflammation, 8, 91.
53. Kumar, P., Kaundal, R.K., More, S. and Sharma, S.S. (2009) Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease. Behav. Brain Res., 197, 398-403.
54. Dusonchet, J., Bensadoun, J.C., Schneider, B.L. and Aebischer, P. (2009) Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease. Neurobiol. Dis., 35, 32-41.
55. Pruszak, J., Just, L., Isacson, O. and Nikkhah, G. (2009) Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons from rodent brains. Curr. Protoc. Stem Cell Biol., Chapter 2, Unit 2D 5.
56. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
57. Schmittgen, T.D. and Livak, K.J. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
58. Dusonchet, J., Kochubey, O., Stafa, K., Young, S.M. Jr, Zufferey, R., Moore, D.J., Schneider, B.L. and Aebischer, P. (2011) A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2. J. Neurosci., 31, 907-912.